eflornithine has been researched along with Asthenia in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benhamou, PH | 1 |
| Chandenier, J | 1 |
| Schechter, PJ | 1 |
| Epelbaum, S | 1 |
| Tell, GP | 1 |
| Haegele, KD | 1 |
| Pautard, JC | 1 |
| Piussan, C | 1 |
1 other study available for eflornithine and Asthenia
| Article | Year |
|---|---|
[African trypanosomiasis in children treated with eflornithine. A case].
Topics: Adolescent; Animals; Asthenia; Eflornithine; Female; Headache; Humans; Sleep Wake Disorders; Trypano | 1989 |